Raymond James Financial Inc. purchased a new position in shares of Northrim BanCorp, Inc. (NASDAQ:NRIM – Free Report) in the ...

BROOKLYN, N.Y. - Etsy, Inc. (NASDAQ: ETSY), a global online marketplace, announced the appointment of Rafe Colburn as its Chief Technology Officer ... investments. Raymond James cut its target ...

Raymond James Financial Inc. purchased a new position ... Following the completion of the sale, the chief executive officer now owns 179,096 shares in the company, valued at approximately $ ...

Wealth Enhancement Group announced that is set to acquire a registered investment advisory firm in Ohio. Wealth Enhancement's latest planned addition is Cleveland-based Marcum Wealth, a firm founded ...

Greetings, and welcome to the Spire Global fourth-quarter and full year 2024 call. (Operator Instructions) And as a reminder, this conference is being recorded. It is now my pleasure to introduce your ...

David Burton, the senior fellow in economic policy at the Heritage Foundation who authored Project 2025’s section on securities regulation, says Finra’s oversight of the broker-dealer industry is ...

Q4 2025 Earnings Conference Call April 1, 2025 4:30 PM ETCompany ParticipantsHarrison Masters - Director, IRSean Desmond - ...

Synapse Summit 2025 embraced a bold new direction, scaling down attendance but also doubling down on Tampa Bay’s strengths ...

Q4 2024 Earnings Call Transcript March 31, 2025 Alpha Cognition Inc. Common Stock misses on earnings expectations. Reported EPS is $-0.51 EPS, expectations were $-0.48. Operator: Greetings, and ...

Summit Hotel Properties, Inc. (the "Company") today announced that it has successfully closed on a new $275 million senior unsecured term loan (the "Term Loan").  The Company expects to utilize future ...

Researchers at academic institutions nationwide say that U.S. science is being dismantled. Government Science Data: Vast ...

Lomond Therapeutics Holdings, Inc. ("Lomond Therapeutics"), a clinical-stage biotechnology company dedicated to discovering and developing potentially best-in-class and first-in-class medicines for ...